BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 16860003)

  • 1. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.
    Herasimenka Y; Cescutti P; Impallomeni G; Campana S; Taccetti G; Ravenni N; Zanetti F; Rizzo R
    J Cyst Fibros; 2007 Apr; 6(2):145-52. PubMed ID: 16860003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M
    Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.
    Carvalho AP; Ventura GM; Pereira CB; Leão RS; Folescu TW; Higa L; Teixeira LM; Plotkowski MC; Merquior VL; Albano RM; Marques EA
    APMIS; 2007 Apr; 115(4):311-8. PubMed ID: 17504297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exopolysaccharides produced by Burkholderia cenocepacia recA lineages IIIA and IIIB.
    Chiarini L; Cescutti P; Drigo L; Impallomeni G; Herasimenka Y; Bevivino A; Dalmastri C; Tabacchioni S; Manno G; Zanetti F; Rizzo R
    J Cyst Fibros; 2004 Aug; 3(3):165-72. PubMed ID: 15463903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
    Jones AM; Dodd ME; Govan JR; Barcus V; Doherty CJ; Morris J; Webb AK
    Thorax; 2004 Nov; 59(11):948-51. PubMed ID: 15516469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources.
    Seo ST; Tsuchiya K
    Lett Appl Microbiol; 2004; 39(5):413-9. PubMed ID: 15482431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
    McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
    J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation and identification of Burkholderia cepacia complex from cystic fibrosis patients].
    Yurdakul P; Ergünay K; Yalçin E; Doğru D; Sener B; Cobanoğlu N; Ozçelik U; Kiper N
    Mikrobiyol Bul; 2006 Oct; 40(4):301-6. PubMed ID: 17205687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report of a lyase for cepacian, the polysaccharide produced by Burkholderia cepacia complex bacteria.
    Cescutti P; Scussolin S; Herasimenka Y; Impallomeni G; Bicego M; Rizzo R
    Biochem Biophys Res Commun; 2006 Jan; 339(3):821-6. PubMed ID: 16325774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
    Kidd TJ; Douglas JM; Bergh HA; Coulter C; Bell SC
    Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.
    Coenye T; LiPuma JJ; Henry D; Hoste B; Vandemeulebroecke K; Gillis M; Speert DP; Vandamme P
    Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):271-9. PubMed ID: 11321071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres.
    Boussaud V; Guillemain R; Grenet D; Coley N; Souilamas R; Bonnette P; Stern M
    Thorax; 2008 Aug; 63(8):732-7. PubMed ID: 18408050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from sputum of patients with cystic fibrosis.
    Moore JE; Xu J; Millar BC; Crowe M; Elborn JS
    J Microbiol Methods; 2002 Apr; 49(2):183-91. PubMed ID: 11830304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
    Drevinek P; Mahenthiralingam E
    Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression-subtractive hybridisation reveals variations in gene distribution amongst the Burkholderia cepacia complex, including the presence in some strains of a genomic island containing putative polysaccharide production genes.
    Parsons YN; Banasko R; Detsika MG; Duangsonk K; Rainbow L; Hart CA; Winstanley C
    Arch Microbiol; 2003 Mar; 179(3):214-23. PubMed ID: 12610727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence divergence in type III secretion gene clusters of the Burkholderia cepacia complex.
    Glendinning KJ; Parsons YN; Duangsonk K; Hales BA; Humphreys D; Hart CA; Winstanley C
    FEMS Microbiol Lett; 2004 Jun; 235(2):229-35. PubMed ID: 15183868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous coinfection by multiple strains during Burkholderia cepacia complex infection in cystic fibrosis.
    Yang JH; Spilker T; LiPuma JJ
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):95-8. PubMed ID: 16406186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.
    Campana S; Taccetti G; Ravenni N; Favari F; Cariani L; Sciacca A; Savoia D; Collura A; Fiscarelli E; De Intinis G; Busetti M; Cipolloni A; d'Aprile A; Provenzano E; Collebrusco I; Frontini P; Stassi G; Trancassini M; Tovagliari D; Lavitola A; Doherty CJ; Coenye T; Govan JR; Vandamme P
    J Clin Microbiol; 2005 Oct; 43(10):5136-42. PubMed ID: 16207975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
    Manno G; Dalmastri C; Tabacchioni S; Vandamme P; Lorini R; Minicucci L; Romano L; Giannattasio A; Chiarini L; Bevivino A
    J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.